...
首页> 外文期刊>Pharmaceutical sciences. >Effects of Aloe Vera Supplements on Blood Glucose Level and Lipid Profile Markers in Type 2 Diabetic Patients – a Randomized Clinical Trial
【24h】

Effects of Aloe Vera Supplements on Blood Glucose Level and Lipid Profile Markers in Type 2 Diabetic Patients – a Randomized Clinical Trial

机译:芦荟补充剂对2型糖尿病患者血糖水平和脂质谱标记的影响–一项随机临床试验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

One of the most studied methods to adjust the blood glucose level and dyslipidemia in diabetic patients is administrating of herbal supplements. This double blinded randomized clinical trial (RCT) study we are aimed to study the effect of Aloe vera supplements on blood glucose level and lipid profile of diabetes mellitus type 2 patients. Methods: 44 patients (25 male and 19 female) fulfilling inclusion criteria, were divided into two groups of intervention and placebo randomly. The patients in intervention group received 1000 mg of Aloe vera supplements and the patients of placebo group received placebo, daily for two months beside the main treatment for diabetes mellitus. Before and after the intervention blood samples were taken from all the patients; and were measured for blood glucose level and lipid profile. The data were analyzed using independent T-test method. This RCT study was submitted in IRCT center by submitted code of IRCT201307269626N3. Results: The results revealed that the levels of the fasting blood sugar (FBS), HbA1c, Total Cholesterol, Triglyceride, high density lipoprotein (HDL), low density lipoprotein (LDL) were not significantly different between the pre-intervention and post intervention blood samples in both intervention and placebo group. Also there was not any significant difference in blood glucose level and lipid profile comparing intervention and placebo groups. Conclusion: In this study, we can conclude that Aloe vera supplement beside the main treatment for diabetes mellitus has no significant effect in blood glucose level and lipid profile in diabetes mellitus type 2 patients.
机译:调整糖尿病患者血糖水平和血脂异常的研究最多的方法之一是服用草药补品。这项双盲随机临床试验(RCT)研究旨在研究芦荟补充剂对2型糖尿病患者血糖水平和血脂水平的影响。方法:将符合入选标准的44例患者(男25例,女19例)随机分为两组,即干预组和安慰剂组。干预组患者接受1000 mg芦荟补充剂,安慰剂组患者接受安慰剂,每天两次,主要用于糖尿病治疗。干预前后均从所有患者中采集血样。并测量血糖水平和血脂水平。使用独立的T检验方法分析数据。这项RCT研究是通过IRCT201307269626N3提交的代码在IRCT中心提交的。结果:结果显示,干预前和干预后血液的空腹血糖(FBS),HbA1c,总胆固醇,甘油三酸酯,高密度脂蛋白(HDL),低密度脂蛋白(LDL)的水平无显着差异。干预组和安慰剂组的样本。与干预组和安慰剂组相比,血糖水平和血脂水平也没有任何显着差异。结论:在这项研究中,我们可以得出结论,芦荟补充剂除了主要治疗糖尿病外,对2型糖尿病患者的血糖水平和血脂水平没有显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号